Millions of Britons using weight-loss medications have reduced their grocery spending by over £1 billion, with significant drops observed in sales of alcohol and crisps. According to market researchers Worldpanel by Numerator, 2.6 million households in the UK now have at least one person taking these appetite-suppressing drugs, a figure comparable to the combined number of vegans and pescatarians.

The number of households with users of GLP-1 medications, sold under brand names such as Mounjaro and Wegovy, has risen to 8.5 percent, a more than threefold increase from 2.3 percent two years ago. This trend represents a "seismic change" that requires retailers and manufacturers to re-evaluate their strategies, according to Chantel Kennaugh, head of public sector and nutrition at Worldpanel by Numerator.

The impact on consumer spending is substantial, with the group of users collectively reducing their grocery spend by £1 billion annually, up from £780 million in June. This amounts to approximately £389 less spent per patient's basket each year. The study, which analyzed 9,629 households, also noted that weight-loss pills now constitute 11.2 percent of GLP-1 users, despite their recent approval in the UK.

Men now make up 32 percent of users, nearly double the 23 percent recorded in February, indicating a broadening demographic for these medications. Spending on alcohol among users has decreased by 15 percent compared to households not using the drugs, partly attributed to the medications making drinking less appealing and causing side effects like nausea. Spending on crisps has also seen a 15 percent decline within this user group.

However, some sectors are experiencing increased demand. Households using these medications have spent an additional £78 million on health and beauty products in the first year of adoption. Furthermore, 30 percent reported increased spending on clothing and footwear as their bodies changed. Products like mouthwash have benefited from users addressing side effects such as dry mouth. Some consumers are also seeking affordable indulgences due to reduced disposable income caused by the medications, which can cost up to £350 per month. This may explain a rise in spending on hot chocolate and smaller chocolate portions, as users also become sensitive to stimulants like coffee.

This trend aligns with observations from Tesco's chief executive, Ken Murphy, who predicted a more moderate Christmas in terms of alcohol consumption due to increased interest in healthy lifestyles.